THK Co., Ltd.
THK Co., Ltd. (THKLY) Financial Performance & Income Statement Overview
Analyze THK Co., Ltd. (THKLY) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
THK Co., Ltd. (THKLY) Income Statement & Financial Overview
View the income breakdown for THK Co., Ltd. THKLY across both annual and quarterly reports.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $84.95B | $87.63B | $85.28B | $94.72B |
| Cost of Revenue | $66.45B | $66.34B | $64.66B | $73.02B |
| Gross Profit | $18.49B | $21.28B | $20.62B | $21.70B |
| Gross Profit Ratio | $0.22 | $0.24 | $0.24 | $0.23 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $16.78B | $16.36B | $15.85B | $15.82B |
| Operating Expenses | $16.78B | $16.85B | $16.10B | $15.82B |
| Total Costs & Expenses | $83.24B | $83.20B | $80.76B | $88.84B |
| Interest Income | $1.12B | $905.00M | $0.00 | $1.46B |
| Interest Expense | $1.26B | $246.00M | $0.00 | $408.00M |
| Depreciation & Amortization | $6.08B | $6.13B | $6.09B | $5.97B |
| EBITDA | $9.15B | $10.60B | $10.54B | $13.69B |
| EBITDA Ratio | $0.11 | $0.12 | $0.12 | $0.14 |
| Operating Income | $1.71B | $4.43B | $4.52B | $5.88B |
| Operating Income Ratio | $0.02 | $0.05 | $0.05 | $0.06 |
| Other Income/Expenses (Net) | $90.00M | $703.00M | -$905.00M | $1.45B |
| Income Before Tax | $1.80B | $5.13B | $3.62B | $7.33B |
| Income Before Tax Ratio | $0.02 | $0.06 | $0.04 | $0.08 |
| Income Tax Expense | $1.09B | $3.91B | $1.50B | $1.98B |
| Net Income | $319.00M | $1.25B | $1.98B | $5.25B |
| Net Income Ratio | $0.004 | $0.01 | $0.02 | $0.06 |
| EPS | $2.75 | $10.20 | $16.12 | $42.84 |
| Diluted EPS | $2.75 | $10.20 | $16.12 | $42.84 |
| Weighted Avg Shares Outstanding | $115.85M | $122.45M | $122.61M | $122.60M |
| Weighted Avg Shares Outstanding (Diluted) | $115.85M | $122.45M | $122.61M | $122.60M |
Over the last four quarters, THK Co., Ltd.'s revenue moved from $94.72B in Q2 2024 to $84.95B in Q1 2025. Operating income in Q1 2025 was $1.71B, with a strong operating margin of 2%. Despite fluctuations in R&D and SG&A expenses, EBITDA for THK Co., Ltd. remained robust at $9.15B, reflecting operational efficiency. Net income dropped to $319.00M, with an EPS of $2.75. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan